These results demonstrate that the elevated synthesis and release of active lysosomal cathepsins upon TMEM106B expression, could create an invasive microenvironment conducive for metastatic spread of cancer cells and could be therapeutically targeted using a cathepsin inhibitor. Here, TMEM106B is linked to cancer.